Paper · 40831701
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 92
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26422227 | Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. | Cell | 2015 | https://conductscience.org/library/papers/26422227 | PubMed |
| 2 | 36121194 | CRISPR/Cas9-HPV-liposome enhances antitumor immunity and treatment of HPV infection-associated cervical cancer. | J Med Virol | 2023 | https://conductscience.org/library/papers/36121194 | PubMed |
| 3 | 25031569 | Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis. | Genomics Inform | 2014 | https://conductscience.org/library/papers/25031569 | PubMed |
| 4 | 32243786 | CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors. | Cell | 2020 | https://conductscience.org/library/papers/32243786 | PubMed |
| 5 | 26762611 | Role of Human Papillomavirus in Penile Carcinomas Worldwide. | Eur Urol | 2016 | https://conductscience.org/library/papers/26762611 | PubMed |
| 6 | 37403986 | Systemic delivery of specific and efficient CRISPR/Cas9 system targeting HPV16 oncogenes using LL-37 antimicrobial peptide in C57BL/6 mice. | J Med Virol | 2023 | https://conductscience.org/library/papers/37403986 | PubMed |
| 7 | 32695664 | High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions. | Front Oncol | 2020 | https://conductscience.org/library/papers/32695664 | PubMed |
| 8 | 28143725 | Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes. | Virus Res | 2017 | https://conductscience.org/library/papers/28143725 | PubMed |
| 9 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 10 | 30670702 | Engineering of CRISPR-Cas12b for human genome editing. | Nat Commun | 2019 | https://conductscience.org/library/papers/30670702 | PubMed |
| 11 | 28798073 | The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. | Clin Sci (Lond) | 2017 | https://conductscience.org/library/papers/28798073 | PubMed |
| 12 | 25136604 | Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25136604 | PubMed |
| 13 | 21892917 | PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. | Curr Drug Metab | 2012 | https://conductscience.org/library/papers/21892917 | PubMed |
| 14 | 24817381 | Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. | Int J Cancer | 2015 | https://conductscience.org/library/papers/24817381 | PubMed |
| 15 | 29215041 | CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes. | Sci Rep | 2017 | https://conductscience.org/library/papers/29215041 | PubMed |
| 16 | 24854633 | Identification and characterization of small molecule human papillomavirus E6 inhibitors. | ACS Chem Biol | 2014 | https://conductscience.org/library/papers/24854633 | PubMed |
| 17 | 33432198 | Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice. | Nat Biotechnol | 2021 | https://conductscience.org/library/papers/33432198 | PubMed |
| 18 | 12353208 | External genital warts: diagnosis, treatment, and prevention. | Clin Infect Dis | 2002 | https://conductscience.org/library/papers/12353208 | PubMed |
| 19 | 25830891 | In vivo genome editing using Staphylococcus aureus Cas9. | Nature | 2015 | https://conductscience.org/library/papers/25830891 | PubMed |
| 20 | 29704747 | Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities. | Biomaterials | 2018 | https://conductscience.org/library/papers/29704747 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/40831701/references